Telomir Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Telomir Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Telomir Pharmaceuticals Inc
Rating: 0.96933325
Author: Trendlyne DVM scores

about

Telomir Pharmaceuticals Inc is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone. ...

1.27 0.04 (3.25%)

59.03% Fall from 52W High

74,851

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The latest board meeting for Telomir Pharma Inc took place on 14 May 2026, for the purpose of Telomir Pharmaceuticals Inc First Quarter Earnings Results for 2026 See details

Not Eligible

Expensive Valuation

2.3 / 100

Technically Neutral

36.4 / 100

No estimates available

Telomir Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Telomir Pharma Inc Live Stock Price Today, Share Analysis and Chart

Telomir Pharmaceuticals Inc is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone. ...

59.03% Fall from 52W High

SWOT Analysis

Telomir Pharma Inc Live Price Chart